Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP

Journal of Surgical Research

Volumn 70, Issue 1, 1997, Pages 75-83

  Wilson, Peter S ^a   Thompson, W Joseph ^a   Moore, Timothy M ^a   Khimenko, Pavel L ^a   Taylor, Aubrey E ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 ANILINO 5,8 QUINOLINEQUINONE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; FLOW RATE; ISOLATED LUNG; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; VASOCONSTRICTION;

EID: 0031171358     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5095     Document Type: Article

References (30)

1. Barnes P. J., Liu S. F. Regulation of pulmonary vascular tone. Pharmacol. Rev. 47:1995;87.
2. Fineman J. R., Soifer S. J., Heymann M. A. Regulation of pulmonary vascular tone in the perinatal period. Annu. Rev. Physiol. 57:1995;115.
3. GL. Circ. Res. 67:1990;979.
4. Lincoln T. M., Cornwell T. L. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328.
5. +NN. Neurosc. Lett. 68:1986;95.
6. ωL. Am. J. Physiol. 260:1991;H1299.
7. ωL. J. Appl. Physiol. 71:1991;2026.
8. Persson M. G., Gustafsson L. E., Wiklund N. P., Moncada S., Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol. Scand. 140:1990;449.
9. Hasunuma K., Yamaguchi T., Rodman D. M., O'Brien R. F., McMurtry I. F. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am. J. Physiol. 260:1991;L97.
10. Russ R. D., Walker B. R. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. Am. J. Physiol. 262:1992;H743.
11. Pohl U., Herlan K., Huang A., Bassenge E. EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am. J. Physiol. 261:1991;H2016.
12. Koller A., Sun D., Huang A., Kaley G. Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am. J. Physiol. 267:1994;H326.
13. Cornfield D. N., Chatfield B. A., McQueston J. A., McMurtry I. F., Abman S. H. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am. J. Physiol. 262:1992;H1474.
14. Barnard J. W., Wilson P. S., Moore T. M., Thompson W. J., Taylor A. E. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. J. Appl. Physiol. 74:1993;2940.
15. Wilson P. S., Khimenko P. L., Moore T. M., Taylor A. E. Perfusate viscosity and hematocrit determine pulmonary vascular responsiveness to NO synthase inhibitors. Am. J. Physiol. 270:1996;H1757.
16. Barnard J. W., Ward R. A., Adkins W. K., Taylor A. E. Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance. J. Appl. Physiol. 72:1992;1845.
17. Kamiya A., Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am. J. Physiol. 239:1980;H14.
18. Gan R. Z., Yen R. T. Vascular impedance analysis in dog lung with detailed morphometric and elasticity data. J. Appl. Physiol. 77:1994;706.
19. Linehan J. H., Dawson C. A., Rickaby D. A. Distribution of vascular resistance and compliance in a dog lung lobe. J. Appl. Physiol. 53:1982;158.
20. Brooker G., Harper J. G., Terasaki W. L., Moylan R. D. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucl. Res. 10:1979;1.
21. Wilson S. P. Rapid purification of iodinated ligands for cyclic nucleotide radioimmunoassays. Sec. Messenger Phosphoprotein Res. 12:1988;1.
22. Cheatham M. L. A Practical Guide to Biostatistics. 1994;Vanderbilt University, Nashville.
23. Kobzik L., Bredt D. S., Lowenstein C. J., Drazen J., Gaston B., Sugerbaker D., Stamler J. S. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell. Mol. Biol. 9:1993;371.
24. ωL. Eur. J. Pharmacol. 263:1995;133.
25. 2. J. Pharmacol. Exp. Ther. 258:1991;669.
26. Dawson C. A., Bronikowski T. A., Linehan J. H., Rickaby D. A. Distributions of vascular pressure and resistance in the lung. J. Appl. Physiol. 64:1988;274.
27. Schini V., Schoeffter P., Miller R. C. Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta. Br. J. Pharmacol. 97:1989;853.
28. Roberts J. D., Chen T.-Y., Kawai N., Wain J., Dupuy P., Shimouchi A., Bloch K., Polaner D., Zapol W. M. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ. Res. 72:1993;246.
29. Rovira I., Chen T.-Y., Winkler M., Kawai N., Bloch K. D., Zapol W. M. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J. Appl. Physiol. 76:1994;345.
30. Rabe K. F., Tenor H., Dent G., Schudt C., Nakashima M., Magnussen H. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am. J. Physiol. 266:1994;L536.